| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AEW541 | CCLE | pan-cancer | AAC | 0.18 | 3e-05 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.15 | 0.002 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.11 | 0.01 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.092 | 0.04 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | -0.075 | 0.1 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.069 | 0.1 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.064 | 0.2 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.055 | 0.2 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.041 | 0.4 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.038 | 0.4 |